Shortly following the news of Dawson Creek’s star James Van Der Beek’s death after an aggressive battle with cancer, his family started a GoFundMe account. Fans were stunned to learn the actor’s ...

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the ...

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely ...

TROY, Mich.: 20 Jan. 2026 — In a market where affordability pressures are pushing more customers to weigh the total cost of vehicle ownership, the estimated worth of a vehicle at the end of its lease ...

Assessing adjuvant chemotherapy benefit in younger and older molecular residual disease–positive patients with stage II/III colorectal cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Residuals are one of the most essential forms of compensation for DGA members. They ensure that when work continues to generate revenue over time, the people who made it possible share in that ongoing ...

MRD testing is underutilized in clinical practice due to uncertainty in its impact on patient management decisions. The MIDAS trial suggests omitting ASCT in multiple myeloma patients achieving ...

Minimal residual disease (MRD) testing—using circulating tumor DNA (ctDNA) to detect minute traces of cancer after treatment—is generating increased interest in the management of solid tumors. As ...